Dr. Patrick Verta

Dr. Patrick Verta, MD, DVM, MS Stat, has over 25 years of experience in the medical device industry leading clinical and medical affairs in both public and privately held companies. Prior to joining InspireMD, he served as Chief Medical Officer, overseeing medical, clinical affairs and reimbursement at Canary Medical, a developer of implantable remote patient monitoring sensor technology and analytics. Prior to Canary Medical, he was the Founder and President of Axelmed LLC, a consultancy company focused on clinical, medical, reimbursement and regulatory affairs strategies for medical device companies. Before Axelmed, he was Global Vice-President of Medical Affairs at Edwards Lifesciences (NYSE:EW), where he led Medical Affairs, Clinical Science and Biometrics in the Transcatheter Mitral and Tricuspid Therapies (TMTT) division. His previous role at Edward Lifesciences, was as Vice-President and medical director in Business Development.
Prior to Edwards Lifesciences, Dr. Verta served in a variety of leadership roles in the interventional medical device space, to include Chief Medical Officer for the start-up companies Sunshine Heart and Neomend. Prior to that, he served in roles of increasing responsibility at Abbott (NYSE:ABT) and Guidant (acquired by Abbott), where he directed several endovascular clinical science programs that led to the approval of various stents systems in the carotid, renal, and inferior limb anatomies. Of relevance to his current position at InspireMD, he was instrumental in the market authorization of two carotid stents (Acculink and Exact) and two embolic protection devices (Accunet and Emboshield Pro) and led 4 post-market studies that enrolled over 15,000 patients and helped define the field. He was responsible for the approval of the Acculink/Accunet in patients at standard risk for Carotid endarterectomy (the CREST), after a successful FDA circulatory panel vote in 2011. Dr. Verta has extensively published and is recognized internationally as an expert on Carotid Artery Stenting.
Dr. Verta earned his doctorate in medicine from the Faculté de Médecine de Paris XII, and in parallel attended the École Nationale Vétérinaire d’Alfort, where he received his doctorate in veterinary medicine. Dr. Verta also holds a master’s degree in biostatistics from Université de Paris VI.